{"id":"https://openalex.org/W4240150334","doi":"https://doi.org/10.21037/tcr.2017.09.08","title":"Role of pharmacogenetics in personalised imatinib dosing","display_name":"Role of pharmacogenetics in personalised imatinib dosing","publication_year":2017,"publication_date":"2017-12-01","ids":{"openalex":"https://openalex.org/W4240150334","doi":"https://doi.org/10.21037/tcr.2017.09.08","mag":"2761545096"},"language":"en","primary_location":{"id":"doi:10.21037/tcr.2017.09.08","doi":"https://doi.org/10.21037/tcr.2017.09.08","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr.2017.09.08","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.21037/tcr.2017.09.08","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077900083","display_name":"Daniel Thomas Barratt","orcid":"https://orcid.org/0000-0001-6261-353X","observed_orcids":["https://orcid.org/0000-0001-6261-353X"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Daniel T. Barratt","raw_affiliation_strings":["Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia;","Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia;","Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia;","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia;","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089827696","display_name":"Andrew Alexander Somogyi","orcid":"https://orcid.org/0000-0003-4779-0380","observed_orcids":["https://orcid.org/0000-0003-4779-0380"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew A. Somogyi","raw_affiliation_strings":["Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia;","Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia","Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia;","Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia; Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia;","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia;","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, Australia; Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I1320133117","https://openalex.org/I5681781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5077900083"],"corresponding_institution_ids":["https://openalex.org/I5681781"],"apc_list":null,"apc_paid":null,"fwci":1.344,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.74456866,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"6","issue":"S10","first_page":"S1541","last_page":"S1557"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9800000190734863},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.9589999914169312},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cyp2c8","display_name":"CYP2C8","score":0.8299999833106995},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.7599999904632568},{"id":"https://openalex.org/keywords/intracellular-drug-distribution","display_name":"intracellular drug distribution","score":0.6990000009536743},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7850000262260437},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.9186891317367554},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7339722514152527},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.6991555094718933},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.6716790199279785},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6046980619430542},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.5970394611358643},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5079429745674133},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.49961018562316895},{"id":"https://openalex.org/C2776598434","wikidata":"https://www.wikidata.org/wiki/Q18035517","display_name":"SLCO1B1","level":5,"score":0.4494202435016632},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.4134577512741089},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.41081029176712036},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.4089697599411011},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39549893140792847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3681753873825073},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33610162138938904},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2952954173088074},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27968573570251465},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15780755877494812},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.137126624584198},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.10586261749267578},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0804324746131897},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0709281861782074}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21037/tcr.2017.09.08","doi":"https://doi.org/10.21037/tcr.2017.09.08","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr.2017.09.08","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},{"id":"mag:2761545096","doi":null,"is_oa":false,"landing_page_url":"https://tcr.amegroups.com/article/viewFile/16228/pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Translational Cancer Research","raw_type":null}],"best_oa_location":{"id":"doi:10.21037/tcr.2017.09.08","doi":"https://doi.org/10.21037/tcr.2017.09.08","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr.2017.09.08","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322506","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281663767","https://openalex.org/W2883916052","https://openalex.org/W3012882426","https://openalex.org/W2151658395","https://openalex.org/W7097642264","https://openalex.org/W2055980828","https://openalex.org/W2567083292","https://openalex.org/W2061176374","https://openalex.org/W2613592770","https://openalex.org/W2493479489"],"abstract_inverted_index":{"Abstract:":[0],"Imatinib":[1,48,130,174],"is":[2,36,49,61,111,131,156,175,195,263,315,344],"the":[3,14,27,75,186,359],"original":[4],"tyrosine":[5],"kinase":[6],"inhibitor":[7],"specifically":[8],"designed":[9],"and":[10,35,45,67,136,146,171,181,219,241,366,371],"clinically":[11],"used":[12,30],"for":[13,33,128,179,342,376],"molecularly":[15],"targeted":[16],"treatment":[17,78,116,233],"of":[18,26,72,96,198,204,210,231,247,358],"chronic":[19],"myeloid":[20],"leukaemia":[21],"(CML).":[22],"It":[23],"remains":[24],"one":[25],"most":[28],"widely":[29],"first-line":[31],"treatments":[32],"CML,":[34],"now":[37],"also":[38,92,176],"indicated":[39],"in":[40,138,151,185],"multiple":[41],"other":[42],"BCR-ABL-,":[43],"c-KIT-":[44],"PDGFR-driven":[46],"cancers.":[47],"orally":[50],"administered,":[51],"predominantly":[52],"hepatically":[53],"cleared":[54],"with":[55,81,94,123,238],"a":[56,120,124,177,306,320],"low":[57],"hepatic":[58],"extraction":[59],"ratio,":[60],"95%":[62],"bound":[63],"to":[64,101,114,119,223,258,270,296,303,318,323,333,353,369],"plasma":[65,82,214],"proteins,":[66],"has":[68],"an":[69,196,245,345],"intracellular":[70,276,364],"site":[71],"action.":[73],"In":[74,300],"CML":[76,106,152,189,232,254],"setting,":[77],"outcomes":[79,91,117],"correlate":[80,93],"imatinib":[83,103,109,144,148,169,215,251,274,287,311,325,343,363,378],"concentrations,":[84],"which":[85,193],"show":[86],"large":[87],"interpatient":[88],"variability.":[89],"Treatment":[90],"markers":[95],"drug":[97,336],"transporter":[98,211,239,248],"variability":[99],"considered":[100],"influence":[102,309],"distribution":[104,252,365],"into":[105,253],"cells.":[107,255],"Personalised":[108],"dosing":[110],"therefore":[112],"expected":[113],"improve":[115],"compared":[118],"\u201cone-dose-fits-all\u201d":[121],"approach,":[122],"potential":[125,307,334],"additional":[126],"role":[127],"pharmacogenetics.":[129],"metabolised":[132],"by":[133],"CYPs":[134],"2C8":[135],"3A4":[137],"vitro.":[139],"CYP2C8":[140],"genotype":[141],"significantly":[142],"affects":[143],"metabolism,":[145],"consequently":[147],"systemic":[149],"exposure":[150],"patients.":[153],"Conversely,":[154],"there":[155],"no":[157,207],"consistent":[158],"evidence":[159,314],"that":[160],"CYP3A4":[161],"or":[162,166,217,278,338],"CYP3A5":[163],"inhibitors,":[164],"inducers":[165],"genetics":[167,249],"alter":[168],"metabolism":[170],"pharmacokinetics":[172],"clinically.":[173],"substrate":[178],"uptake":[180],"efflux":[182],"transporters":[183,194],"expressed":[184],"liver":[187],"and/or":[188],"cells,":[190],"although":[191],"exactly":[192],"area":[197],"open":[199],"debate.":[200],"The":[201],"clear":[202],"majority":[203],"studies":[205,302],"indicate":[206,305],"significant":[208],"effect":[209,246],"genotypes":[212],"on":[213,250,273,310],"concentrations":[216],"clearance,":[218,275],"any":[220],"positive":[221],"findings":[222],"date":[224,304],"have":[225,235],"not":[226],"been":[227,236],"replicated.":[228],"Various":[229],"measures":[230],"outcome":[234],"correlated":[237],"genotype,":[240],"from":[242],"this":[243],"implied":[244],"However,":[256],"due":[257,269],"study":[259,349],"design":[260],"limitations":[261],"it":[262],"unclear":[264],"if":[265],"these":[266],"observations":[267],"are":[268,351],"genetic":[271,284,308],"effects":[272],"distribution,":[277],"possibly":[279],"neither.":[280],"Other":[281],"potentially":[282],"novel":[283],"factors":[285,360],"influencing":[286],"disposition,":[288,312],"such":[289],"as":[290],"xenobiotic-responsive":[291],"receptor":[292],"gene":[293],"polymorphisms,":[294],"remain":[295],"be":[297,331],"thoroughly":[298],"investigated.":[299],"summary,":[301],"however":[313],"still":[316],"lacking":[317],"support":[319],"pharmacogenomic":[321,328],"approach":[322],"personalised":[324,377],"dosing.":[326,379],"Whether":[327],"information":[329],"might":[330],"complementary":[332],"therapeutic":[335],"monitoring":[337],"target":[339],"concentration":[340],"intervention":[341],"ongoing":[346],"question.":[347],"Improved":[348],"designs":[350],"required":[352],"gain":[354],"greater":[355],"mechanistic":[356],"understanding":[357],"governing":[361],"variable":[362],"its":[367],"relationship":[368],"response,":[370],"move":[372],"toward":[373],"improved":[374],"tools":[375]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}